Microbiology and mortality of pediatric febrile neutropenia in El Salvador

Journal of Pediatric Hematology/Oncology

Volumn 33, Issue 4, 2011, Pages 276-280

  Gupta, Sumit ^a   Bonilla, Miguel ^b   Gamero, Mario ^b   Fuentes, Soad L ^b   Caniza, Miguela ^c,d   Sung, Lillian ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b Benjamin Bloom National Children's Hospital   (El Salvador)

^c Department of Infectious Diseases ^*  (United States)

^d ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

cancer; developing countries; fever; neutropenia; pneumonia

Indexed keywords

ADOLESCENT; AGE; ARTICLE; BACTERIAL PNEUMONIA; CHILD; CHILDHOOD MORTALITY; EL SALVADOR; FEBRILE NEUTROPENIA; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HIGH RISK PATIENT; HUMAN; INFANT; INFECTION CONTROL; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SCHOOL CHILD;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; EL SALVADOR; FEMALE; FEVER; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; INFANT; MALE; NEOPLASMS; NEUTROPENIA; PNEUMONIA, BACTERIAL; PREDICTIVE VALUE OF TESTS; PREVALENCE; RISK FACTORS;

EID: 79955499234     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e31820ff632     Document Type: Article

References (29)

1. Ellison LF, Pogany L, Mery LS. Childhood and adolescent cancer survival: a period analysis of data from the canadian cancer registry. Eur J Cancer. 2007;43:1967-1975. (Pubitemid 47299198)
2. Howard SC, Wilimas JA. Delays in diagnosis and treatment of childhood cancer: where in the world are they important? Pediatr Blood Cancer. 2005;44:303-304. (Pubitemid 40316022)
3. Gupta S, Bonilla M, Fuentes SL, et al. Incidence and predictors of treatment-related mortality in paediatric acute leukaemia in El Salvador. Br J Cancer. 2009;100:1026-1031.
4. Basu SK, Fernandez ID, Fisher SG, et al. Length of stay and mortality associated with febrile neutropenia among children with cancer. J Clin Oncol. 2005;23:7958-7966. (Pubitemid 46657396)
5. Baorto EP, Aquino VM, Mullen CA, et al. Clinical parameters associated with low bacteremia risk in 1100 pediatric oncology patients with fever and neutropenia. Cancer. 2001;92:909-913. (Pubitemid 32783080)
6. Duncan C, Chisholm JC, Freeman S, et al. A prospective study of admissions for febrile neutropenia in secondary paediatric units in South East England. Pediatr Blood Cancer. 2007; 49:678-681. (Pubitemid 350194434)
7. Hann IM, Viscoli C, Paesmans M, et al. A comparison of outcome from frebrile neutropenic episodes in children compared wtih adults: results from four EORTC studies. Br J Haematol. 1997;99:580-588. (Pubitemid 27519860)
8. Klassen RJ, Goodman TR, Ba P, et al. "Low-risk" prediction rule for pediatric oncology patients presenting with fever and neutropenia. J Clin Oncol. 2000;18:1012-1019. (Pubitemid 30123777)
9. Lucas KG, Brown AE, Armstrong D, et al. The identification of febrile, neutropenic children with neoplastic disease at low risk of bacteremia and complications of sepsis. Cancer. 1996;77:791-798. (Pubitemid 26055407)
10. Rackoff W, Gonin R, Robinson C, et al. Predicting the risk of bacteremia in children with fever and neutropenia. J Clin Oncol. 1996;14:919-924. (Pubitemid 26085537)
11. Santolaya ME, Alvarez AM, Becker A, et al. Prospective, multicenter evaluation of risk factors associated with invasive bacterial infection in children with cancer, neutropenia, and fever. J Clin Oncol. 2001;19:3415-3421. (Pubitemid 32642195)
12. Rondinelli PIP, Ribeiro KCB, de Camargo B. A proposed score for predicting severe infection complications in children with chemotherapy-induced febrile neutropenia. J Pediat Hematol Oncol. 2006;28:665-670. (Pubitemid 44540164)
13. Tezcan G, Kupesiz A, Ozturk F, et al. Episodes of fever and neutropenia in children with cancer in a tertiary care medical center in Turkey. Pediatr Hematol Oncol. 2006;23:217-229. (Pubitemid 43361804)
14. Stabell N, Nordal E, Stensvold E, et al. Febrile neutropenia in children with cancer: a retrospective norwegian multicentre study of clinical and microbiological outcome. Scand J Infect Dis. 2008;40:301-307. (Pubitemid 351447992)
15. Klastersky J, Ameye L, Maertens J, et al. Bacteraemia in febrile neutropenic cancer patients. Int J Antimicrob Agents. 2007;30S:S51-59.
16. Ammann RA, Hirt A, Luthy AR, et al. Predicting bacteremia in children with fever and chemotherapy-induced neutropenia. Pediatr Infect Dis J. 2004;23:61-67. (Pubitemid 38176764)
17. Greenberg D, Moser A, Yagupsky P, et al. Microbiological spectrum and susceptibility patterns of pathogens causing bacteraemia in paediatric febrile neutropenic oncology patients: comparsion between two consecutive time periods with use of different antibiotic treatment protocols. Int J Antimicrob Agents. 2005;25:469-473. (Pubitemid 40732600)
18. Yilmaz S, Oren H, Demircioglu F, et al. Assessment of febrile neutropenia episodes in children with acute leukemia treated with BFM protocols. Pediatr Hematol Oncol. 2008;25:195-204. (Pubitemid 351577391)
19. Sung L, Lange BJ, Gerbing RB, et al. Microbiologically documented infections and infection-related mortality in children with acute myeloid leukemia. Blood. 2007;110:3532-3539. (Pubitemid 350159617)
20. Madsen K, Rosenman M, Hui S, et al. Value of electronic data for model validation and refinement: bacteremia risk in children with fever and neturopenia. J Pediat Hematol Oncol. 2002;24:256-262. (Pubitemid 34506611)
21. West DC, Marcin JP, Mawis R, et al. Children with cancer, fever, and treatment-induced neutropenia: Risk factors associated with illness requiring the administration of critical care therapies. Pediatr Emerg Care. 2004;20:79-84. (Pubitemid 38235414)
22. Jones GR, Konsler GK, Dunaway RP, et al. Infection risk factors in febrile, neutropenic children and adolescents. Pediatr Hematol Oncol. 1996;13:217-229. (Pubitemid 26146273)
23. Ammann RA, Bodmer N, Hirt A, et al. Predicting adverse events in children with fever and chemotherapy-induced neutropenia: the prospective multicenter SPOG 2003 FN study. J Clin Oncol. 2010;28:2008-2014.
24. Hakim H, Flynn P, Srivastava DK, et al. Risk prediction in pediatric cancer patients with fever and neutropenia. Pediatr Infect Dis J. 2010;29:53-59.
25. How We Classify Countries. The World Bank; 2009. Available at: http://web.worldbank.org/WBSITE/EXTERNAL/DATAS TATISTICS/0,contentMDK: 20420458~menuPK:64133156~ pagePK:64133150~piPK:64133175~theSitePK:239419,00. html. Accessed November 1, 2009.
26. Santolaya ME, Alvarez AM, Aviles CL, et al. Prospective evaluation of a model of prediction of invasive bacterial infection risk among children with cancer, fever, and neutropenia. Clin Infect Dis. 2002;35:678-683. (Pubitemid 35024727)
27. Rackoff W, Breitfeld PP. Risk factors in children with fever and neutropenia. J Clin Oncol. 2001;19:4270.
28. Alexander SW, Wade KC, Hibberd PL, et al. Evaluation of risk prediction criteria for epsiodes of febrile neutropenia in children with cancer. J Pediatr Hematol Oncol. 2002;24:38-42. (Pubitemid 34094328)
29. Lehrnbecher T, Varwig D, Kaiser J, et al. Infectious complications in pediatric acute myeloid leukemia: analysis of the prospective multi-institutional clinical trial AML-BFM. Leukemia. 2004;18:72-77. 281-288 (Pubitemid 38159441)